American Healthcare REIT (AHR) Proxy Filing summary

Executive summary

• The annual meeting is scheduled for November 7, 2024, to elect nine directors, ratify the auditor, approve executive compensation on an advisory basis, and approve a new employee stock purchase plan.

• The company highlights a $4.5 billion healthcare real estate portfolio, 13.6% revenue growth, and a successful public offering in 2024.

• Updates to corporate governance and compensation practices were made in connection with the NYSE listing.

Voting matters and shareholder proposals

• Proposals include electing nine directors for one-year terms, ratifying Deloitte & Touche as auditor, approving executive compensation (say-on-pay), and adopting the 2024 Employee Stock Purchase Plan.

• Shareholders of record as of August 23, 2024, are eligible to vote.

• The board recommends voting FOR all proposals.

Board of directors and corporate governance

• The board consists of nine members, with a majority being independent.

• Committees include Audit, Compensation, and Nominating and Corporate Governance, all composed of independent directors.

• Annual board and committee evaluations are conducted, and diversity is actively considered in director nominations.

• The board is not classified; all directors are elected annually.

• Minimum stock ownership requirements are in place for directors and officers.